David Bumcrot

David Bumcrot

Company: CAMP4 Therapeutics

Job title: CSO


Regulating Gene Expression by Targeting Regulatory RNAs: A Novel Therapeutic Approach 3:15 pm

RegRNAs are non-coding transcripts derived from gene regulatory elements that function as key regulators of transcription Targeting regRNAs with antisense oligonucleotides leads to specific modulation of gene expression Therapeutic modulation of gene expression using this approach has been achieved in vivo demonstrating the potential of regRNA targeting to treat a range of diseasesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.